Ertugliflozin L- pyroglutamic acid
| Product Name | Ertugliflozin L- pyroglutamic acid |
|---|---|
| Alternate Names | Ertugliflozin Impurities, Impurities of Ertugliflozin |
| CAT No. | CS-O-33685 |
| CAS No. | 1210344-83-4 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 566.00 g/mol |
| Mol. For. | C₂₇H₃₂ClNO₁₀ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Ertugliflozin |
| Purity | 95% |
| Therapeutic | Anti-Diabetic |
| Smileys | OC([C@H](CC1)NC1=O)=O.O[C@H]2[C@](OC3)(C4=CC(CC5=CC=C(OCC)C=C5)=C(Cl)C=C4)O[C@]3(CO)[C@@H](O)[C@@H]2O |
| Canonical Smiles | CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl.C1CC(=O)NC1C(=O)O |
| InchIKey | YHIUPZFKHZTLSH-LXYIGGQGSA-N |
| Inchl | InChI=1S/C22H25ClO7.C5H7NO3/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22;7-4-2-1-3(6-4)5(8)9/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3;3H,1-2H2,(H,6,7)(H,8,9)/t18-,19-,20+,21-,22-;3-/m00/s1 |
| IUPAC | (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol;(2S)-5-oxopyrrolidine-2-carboxylic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Ertugliflozin L-pyroglutamic acid is a medication that is used to control high blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. This medication works by blocking the absorption of glucose by the kidneys, causing excess glucose to be eliminated through the urine. It is typically prescribed as part of a comprehensive treatment plan that includes diet and exercise.
Ertugliflozin L-pyroglutamic acid is available in tablet form and is taken orally once a day. The dosage and duration of treatment will depend on the individual's medical history, kidney function, and response to treatment. It is important to follow the prescribed dosage and instructions carefully to ensure optimal results and to avoid any potential side effects.
Chemically, Ertugliflozin L-pyroglutamic acid is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is a white to off-white powder with a molecular formula of C22H25ClO7S and a molecular weight of 470.94 g/mol. It is soluble in water and methanol, but insoluble in organic solvents like ethyl acetate and acetonitrile.
In conclusion, Ertugliflozin L-pyroglutamic acid is an effective medication for treating type 2 diabetes. It works by blocking the absorption of glucose by the kidneys, resulting in lower blood sugar levels. It is important to follow the prescribed dosage and instructions carefully to ensure optimal results and to avoid any potential side effects.
Get an Instant Quote
Related Compounds
Ertugliflozin Dimer Impurity | Ertugliflozin Impurity 2 | Ertugliflozin-Anomer Impurity | Ertugliflozin Isomer Impurity | Methoxy diol Ertugliflozin | Ertugliflozin-Acid Impurity | Tetra-Pivaloyl ertugliflozin | Ertugliflozin Des Hydroxy Impurity | Ertugliflozin aldehyde Impurity | Ertugliflozin C4 epimer impurity |